Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02934321 · ClinicalTrials.gov registry record · NA
Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage
A NA study of Satiety in Healthy Volunteers, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02934321: Completed NA study of Satiety in Healthy Volunteers, sponsored by University of Florida.
NCT02934321 is a NA study of Satiety in Healthy Volunteers that has completed, run by University of Florida. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02934321, a NA study of Satiety in Healthy Volunteers, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Erythritol is a low calorie sugar substitute that is being increasingly used to sweeten beverages and other food items. Greater amounts of erythritol are required to reach the sweetness level of a common soft drink as compared to aspartame, resulting in higher osmolarity for the erythritol sweetened beverage. Since associations have been noted between osmolarity and satiety, investigators propose that an erythritol sweetened beverage may enhance satiety more than a beverage sweetened with aspartame.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Erythritol
- DIETARY_SUPPLEMENT Aspartame
Study Locations (1)
Florida
- University of Florida Clinical Research Center - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2019-08-23 |
| Phase | NA |
What the finished NCT02934321 record still lists
NCT02934321 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Satiety in Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which Erythritol is the first listed.
NCT02934321 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02934321 about?
NCT02934321 is a clinical study titled "Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage". Erythritol is a low calorie sugar substitute that is being increasingly used to sweeten beverages and other food items. Greater amounts of erythritol are required to reach the sweetness level of a common soft drink as compared to aspartame, resulting in higher osmolarity for the erythritol sweetened...
What is the current status of trial NCT02934321?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-09-18. Estimated completion is 2019-08-23.
What conditions does trial NCT02934321 study?
This clinical trial studies the following conditions: Satiety in Healthy Volunteers.
What interventions are being tested in trial NCT02934321?
The interventions under investigation include: Erythritol (DIETARY_SUPPLEMENT), Aspartame (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02934321?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02934321 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02934321's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI